Chujie Bai

442 total citations
26 papers, 307 citations indexed

About

Chujie Bai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Chujie Bai has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Chujie Bai's work include Sarcoma Diagnosis and Treatment (12 papers), Peptidase Inhibition and Analysis (4 papers) and Colorectal and Anal Carcinomas (4 papers). Chujie Bai is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Peptidase Inhibition and Analysis (4 papers) and Colorectal and Anal Carcinomas (4 papers). Chujie Bai collaborates with scholars based in China, Ethiopia and Hong Kong. Chujie Bai's co-authors include Zhengfu Fan, Tian Gao, Zhiwei Fang, Jiayong Liu, Ruifeng Xue, Min Yang, Shu Li, Shu Li, Tao Zhang and Yue Li and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Chujie Bai

26 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chujie Bai China 9 146 108 91 39 39 26 307
Zhengfu Fan China 11 155 1.1× 167 1.5× 142 1.6× 28 0.7× 24 0.6× 34 347
Takahiro Ebata Japan 12 102 0.7× 160 1.5× 152 1.7× 36 0.9× 10 0.3× 34 404
Chau D Vo United States 8 86 0.6× 39 0.4× 58 0.6× 60 1.5× 19 0.5× 12 277
Rongjie Lin China 11 66 0.5× 40 0.4× 135 1.5× 26 0.7× 65 1.7× 30 325
Olena Preobrazhenska Canada 7 125 0.9× 86 0.8× 176 1.9× 21 0.5× 19 0.5× 7 339
Caijuan Huan China 8 169 1.2× 43 0.4× 134 1.5× 38 1.0× 15 0.4× 11 319
Xi He China 11 98 0.7× 149 1.4× 93 1.0× 36 0.9× 13 0.3× 31 312
Yuichi Tsujimoto Japan 9 108 0.7× 65 0.6× 129 1.4× 78 2.0× 7 0.2× 38 314
Bishu Ganguly United States 11 39 0.3× 183 1.7× 122 1.3× 34 0.9× 13 0.3× 17 439
Marco Basiricò Italy 8 75 0.5× 117 1.1× 89 1.0× 30 0.8× 11 0.3× 16 239

Countries citing papers authored by Chujie Bai

Since Specialization
Citations

This map shows the geographic impact of Chujie Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chujie Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chujie Bai more than expected).

Fields of papers citing papers by Chujie Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chujie Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chujie Bai. The network helps show where Chujie Bai may publish in the future.

Co-authorship network of co-authors of Chujie Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Chujie Bai. A scholar is included among the top collaborators of Chujie Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chujie Bai. Chujie Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Zhengfu, Han Liang, Suxia Luo, et al.. (2025). Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial. Journal for ImmunoTherapy of Cancer. 13(1). e010543–e010543. 3 indexed citations
2.
Gao, Tian, Xinyu He, Junyi Wang, et al.. (2025). Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas.. Journal of Clinical Oncology. 43(16_suppl). 11569–11569. 1 indexed citations
3.
Wu, Yan, Wei Guo, Chujie Bai, et al.. (2024). Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial. Clinical Cancer Research. 30(24). 5577–5583. 4 indexed citations
4.
5.
Liu, Jiayong, Tian Gao, Qiuzhong Pan, et al.. (2024). Phase IIA study of high-affinity TCR-T (TAEST16001) targeting NY-ESO-1 in soft tissue sarcoma.. Journal of Clinical Oncology. 42(16_suppl). 11548–11548. 1 indexed citations
6.
Zhao, Dan, Fang Zhou, Weixin Liu, et al.. (2024). Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival. BMC Cancer. 24(1). 340–340. 3 indexed citations
7.
Li, Peng, Chujie Bai, Haoran Zhang, et al.. (2023). Specific gene module pair-based target identification and drug discovery. Frontiers in Pharmacology. 13. 1089217–1089217. 1 indexed citations
8.
Liu, Jiayong, Tian Gao, Shu Li, et al.. (2022). Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma. Clinical Cancer Research. 28(16). 3473–3479. 29 indexed citations
9.
Liu, Jiayong, Zhengfu Fan, Chujie Bai, et al.. (2022). The efficacy of 99mTc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients. Annals of Translational Medicine. 10(2). 95–95. 2 indexed citations
10.
Liu, Jiayong, Ruifeng Xue, Zhengfu Fan, et al.. (2022). Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study. Frontiers in Oncology. 12. 1019911–1019911. 4 indexed citations
11.
Bai, Chujie, et al.. (2022). SNHG9/miR-214-5p/SOX4 feedback loop regulates osteosarcoma progression. Neoplasma. 69(5). 1175–1184. 5 indexed citations
12.
13.
Liu, Jiayong, Zhengfu Fan, Chujie Bai, et al.. (2021). Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma. Annals of Translational Medicine. 9(4). 339–339. 15 indexed citations
14.
Liu, Jiayong, Zhengfu Fan, Shu Li, et al.. (2020). Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases. Annals of Translational Medicine. 8(22). 1493–1493. 8 indexed citations
15.
Gao, Tian, Ling Yu, Zhiwei Fang, et al.. (2020). KIF18B promotes tumor progression in osteosarcoma by activating β-catenin. Cancer Biology and Medicine. 17(2). 371–386. 24 indexed citations
16.
Li, Shu, Zhengfu Fan, Zhiwei Fang, et al.. (2017). Efficacy of vinorelbine combined with low-dose methotrexate for treatment of inoperable desmoid tumor and prognostic factor analysis. Chinese Journal of Cancer Research. 29(5). 455–462. 13 indexed citations
17.
Li, Yue, Chujie Bai, Jie Liu, et al.. (2016). Fenestrated and Chimney Technique for Juxtarenal Aortic Aneurysm: A Systematic Review and Pooled Data Analysis. Scientific Reports. 6(1). 20497–20497. 50 indexed citations
18.
Fan, Zhengfu, Shu Li, Zhiwei Fang, et al.. (2016). [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].. PubMed. 36(1). 39–43. 1 indexed citations
19.
Bai, Chujie, Min Yang, Zhengfu Fan, et al.. (2015). Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma. Journal of Experimental & Clinical Cancer Research. 34(1). 58–58. 53 indexed citations
20.
Wang, Ning, Hou-shan Lü, Zhenpeng Guan, et al.. (2007). Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis. APOPTOSIS. 12(8). 1433–1441. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengfu Fan Breakdown of academic impact, for papers by Takahiro Ebata Breakdown of academic impact, for papers by Chau D Vo Breakdown of academic impact, for papers by Rongjie Lin Breakdown of academic impact, for papers by Olena Preobrazhenska Breakdown of academic impact, for papers by Caijuan Huan Breakdown of academic impact, for papers by Xi He Breakdown of academic impact, for papers by Yuichi Tsujimoto Breakdown of academic impact, for papers by Bishu Ganguly Breakdown of academic impact, for papers by Marco Basiricò
Rankless by CCL
2026